-
June 19: The Week in Cancer NewsA study indicates that a sedentary lifestyle increases risk of death from cancer, and the Food and Drug Administration approves the human papillomavirus vaccine for prevention of head and neck cancer.
by Kate Yandell
-
June 12: The Week in Cancer NewsThe American Cancer Society updates its guidelines on diet and physical activity, and a study projects that caring for Americans with cancer will cost more than $245 billion by 2030.
by Kate Yandell
-
June 5: The Week in Cancer NewsData show that some people with early-stage non-small cell lung cancer can benefit significantly from treatment with a targeted therapy, and COVID-19 slows the rate of enrollment in cancer clinical trials.
by Kate Yandell
-
May 29: The Week in Cancer NewsA study shows that a more tolerable, dose-adjusted chemotherapy regimen can effectively treat a rare lymphoma, and data from registries provide information on which cancer patients are at greatest risk of death from COVID-19.
by Kate Yandell
-
May 22: The Week in Cancer NewsA study finds that metastatic prostate cancer incidence rose after the U.S. Preventive Services Task Force urged against routine PSA testing, and the Food and Drug Administration approves two PARP inhibitors for treatment of prostate cancer.
by Kate Yandell
-
May 15: The Week in Cancer NewsA study indicates that children with cancer are not at increased risks of severe cases of COVID-19, and researchers find that Medicaid expansion was associated with reduced cancer deaths.
by Kate Yandell
-
May 8: The Week in Cancer NewsA study finds that opioid deaths have slightly increased among people with cancer, and the Food and Drug Administration approves a targeted therapy for non-small cell lung cancer.
by Kate Yandell
-
May 1: The Week in Cancer NewsAt the AACR Virtual Annual Meeting I, researchers presented new data on cancer biology, treatment, screening and risk reduction.
by Cancer Today Staff
-
April 24: The Week in Cancer NewsA third of cancer survivors report that they or their partners have stayed in jobs due to concerns about keeping health insurance, and the Food and Drug Administration approves a new treatment for metastatic triple-negative breast cancer.
by Kate Yandell
-
April 17: The Week in Cancer NewsA study shows that antibiotic use prior to starting immunotherapy for melanoma is associated with decreased survival, and the Food and Drug Administration approves a treatment for advanced HER2-positive breast cancer.
by Kate Yandell
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
